The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Subramanian Sanjay since 2019.
This trader's CIK number is 1790246.
At the time of last reporting, Subramanian Sanjay was the SVP, CFO of Inozyme Pharma, Inc.. (stock ticker symbol INZY).
Also see all insider trading activities at Inozyme Pharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | INZY | 27,100 | $99,999 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | OCGN | 0 | $0 | 149,066 | $1,173,559 | 174,657 | $94,996 |
| 2019 | OCGN | 10,000 | $10,800 | 0 | $0 | 0 | $0 |
1. Inozyme Pharma, Inc. (INZY)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-04-19 | INZY | Buy | 27,100 | 3.69 | 99,999 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-10-26 | OCGN | Sale | 10,000 | 11.07 | 110,700 |
| 2021-10-15 | OCGN | Option Ex | 7,990 | 2.19 | 17,498 |
| 2021-10-15 | OCGN | Sale | 7,990 | 9.96 | 79,580 |
| 2021-08-16 | OCGN | Option Ex | 30,000 | .34 | 10,200 |
| 2021-08-16 | OCGN | Sale | 30,000 | 7.22 | 216,600 |
| 2021-07-15 | OCGN | Option Ex | 31,086 | .34 | 10,569 |
| 2021-07-15 | OCGN | Sale | 31,086 | 6.70 | 208,276 |
| 2021-06-15 | OCGN | Sale | 31,000 | 7.00 | 217,000 |
| 2021-06-15 | OCGN | Option Ex | 31,000 | .34 | 10,540 |
| 2021-05-14 | OCGN | Option Ex | 31,000 | .34 | 10,540 |
| 2021-05-14 | OCGN | Sale | 31,000 | 8.18 | 253,673 |
| 2021-04-29 | OCGN | Option Ex | 7,990 | 2.19 | 17,498 |
| 2021-04-29 | OCGN | Sale | 7,990 | 10.98 | 87,730 |
| 2021-01-29 | OCGN | Option Ex | 35,591 | .51 | 18,151 |
| 2019-11-22 | OCGN | Buy | 5,000 | .28 | 1,400 |
| 2019-10-02 | OCGN | Buy | 5,000 | 1.88 | 9,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Subramanian Sanjay (SVP, CFO of Inozyme Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.